NCT00034632View on ClinicalTrials.gov

Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 2001

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Mycoses

Interventions

DRUG

Posaconazole oral suspension

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00034632 - Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) | Biotech Hunter | Biotech Hunter